Meditope Biosciences: Meditope Biosciences Appoints Veteran Biopharma Scientist David Stover to Board of Directors

Pasadena, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- Meditope Biosciences, Inc., a biotechnology company developing novel oncology therapeutics using its proprietary antibody technology platform, today announced the appointment of Dr. David Stover, Ph.D., to the company's board of directors. An accomplished pharmaceutical researcher and scientist, Dr. Stover has more than 25 years of experience in both small-molecule and biologics drug discovery and development. Most recently, he served as head of Agensys, Inc., an Astellas Pharma affiliate focused on antibody and antibody drug conjugate development, where he led a team of 240 employees in the research, clinical manufacturing and development of five investigational new drugs and four clinical proof of concepts during a ...Full story available on Benzinga.com